Related references
Note: Only part of the references are listed.18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation
Thorsten Derlin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Whole-Body Diffusion-Weighted MRI With Apparent Diffusion Coefficient Mapping for Early Response Monitoring in Multiple Myeloma: Preliminary Results
Marius Horger et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
Elena Zamagni et al.
BLOOD (2011)
A new dimension of FDG-PET interpretation: assessment of tumor biology
Thomas C. Kwee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Multiple Myeloma Treatment Response Assessment with Whole-Body Dynamic Contrast-enhanced MR Imaging
Chieh Lin et al.
RADIOLOGY (2010)
Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity
Conor P. Shortt et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Twyla B. Bartel et al.
BLOOD (2009)
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
M. Dimopoulos et al.
LEUKEMIA (2009)
Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging
Tobias Baeuerle et al.
RADIOLOGY (2009)
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe et al.
BLOOD (2008)
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
Bruno Paiva et al.
BLOOD (2008)
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma
Rosa Fonti et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation
N. Kroeger
LEUKEMIA (2007)
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
Elena Zamagni et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
The role of anatomic and functional staging in myeloma: Description of Durie/Salmon PLUS staging system
Brian G. M. Durie
EUROPEAN JOURNAL OF CANCER (2006)
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma:: preliminary results
C Nanni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Role of MRI for the diagnosis and prognosis of multiple myeloma
A Baur-Melnyk et al.
EUROPEAN JOURNAL OF RADIOLOGY (2005)
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals
A Becherer et al.
EUROPEAN JOURNAL OF RADIOLOGY (2005)